Last $0.0000 USD
Change Today -0.0001 / -90.00%
Volume 254.0K
BONU On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

bioneutral group inc (BONU) Snapshot

Open
$0.0000
Previous Close
$0.0001
Day High
$0.0000
Day Low
$0.0000
52 Week High
02/6/14 - $0.0049
52 Week Low
12/17/14 - --
Market Cap
57.5K
Average Volume 10 Days
3.5M
EPS TTM
$-0.02
Shares Outstanding
5.8B
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIONEUTRAL GROUP INC (BONU)

Related News

No related news articles were found.

bioneutral group inc (BONU) Related Businessweek News

No Related Businessweek News Found

bioneutral group inc (BONU) Details

BioNeutral Group, Inc., through its subsidiary, BioNeutral Laboratories Corporation USA, focuses on developing and commercializing a chemistry-based technology that neutralizes harmful environmental contaminants, toxins, and micro-organisms. The company focuses on the commercialization of two classes of product formulations comprising antimicrobials and bioneutralizer. Its anti­microbial formulations include Ygiene products to kill various harmful microbes consisting of virulent gram positive or negative bacteria, viruses, yeast, mold, fungi, and spores, as well as bioterrorism agents, such as anthrax. The company’s bioneutralizer formulations comprise Ogiene products to eliminate or reduce odors of various chemicals, including hydrogen sulfide, formaldehyde, and ammonia, as well as to reduce various greenhouse gases, such as carbon dioxide and sulfur dioxide. BioNeutral Group, Inc. intends to market and sell its products for cleaning, sanitizing, and odor elimination to consumers, acute and long term health care facilities, veterinary clinics and hospitals, livestock production and processing facilities, food processing and packaging, nutraceutical and pharmaceutical processing, biotechnical clean rooms, commercial mold remediation, hospitality and lodging, first responders, waste-water treatment, power generation, and military chemical firms in the United States and internationally. The company was formerly known as Moonshine Creations, Inc. and changed its name to BioNeutral Group, Inc. in December 2008. BioNeutral Group, Inc. was founded in 2003 and is based in Newark, New Jersey.

3 Employees
Last Reported Date: 02/13/14
Founded in 2003

bioneutral group inc (BONU) Top Compensated Officers

Chief Executive Officer, President, Principal...
Total Annual Compensation: $58.8K
Chief Technology Officer, Chief Scientific Of...
Total Annual Compensation: $47.3K
Compensation as of Fiscal Year 2013.

bioneutral group inc (BONU) Key Developments

BioNeutral Group, Inc. Provides Update on Commercial Loan

On October 14, 2014, BioNeutral Group, Inc. completed a commercial loan closing, and pursuant to the closing, issued a promissory note to James R. Solakian in the amount of $175,000. The note bears interest at 20% per annum and is due on May 5, 2015 (maturity date). In addition, the company shall pay to Mr. Solakian a loan origination fee representing 15% of loan advances made by Mr. Solakian to the company. The maximum loan origination fee, based on $175,000 of loan proceeds actually being received by the company, is $26,250. Pursuant to the promissory note, the company received $75,000 at the loan closing and will receive $50,000 on October 28, 2014 and $50,000 on November 30, 2014. On October 10, 2014, the company received an advance of $50,000 on closing from Mr. Solakian. The company anticipates receiving the remaining $25,000 due at closing from Mr. Solakian within a few business day from the date of this report. The proceeds of the loan are to be used for working capital purposes according to an agreed upon budget between the company and Mr. Solakian. To secure payment of the obligations due under the promissory note, the company granted a security interest to Mr. Solakian of up to $250,000 from the net proceeds from the company's application for sale of its New Jersey corporate income tax losses for the years 2009 through 2013 via the 2014 State of New Jersey's Technology Business Tax Certificate Transfer Program offered by the New Jersey Economic Development Authority. The company has agreed to repay the principal along with any accrued and unpaid interest and the loan origination fee, from the sale proceeds of its State of New Jersey's Technology Business Tax Certificate Transfer Program which is expected to occur prior to the maturity date. Mr. Solakian has also received a loan guarantee from Michael Francis, a shareholder and creditor of the company, in the amount of $150,000. On October 13, 2014, the company completed a commercial loan closing, and pursuant to the closing, issued a promissory note to Michael Francis in the amount of $150,000. The note bears interest at 20% per annum and is due on May 5, 2015 (maturity date). In addition, the company shall pay to Mr. Francis a loan origination fee representing 15% of loan advances made by Mr. Francis to the company. The maximum loan origination fee, based on all $150,000 of loan proceeds if received by the company, is $22,500. Pursuant to the promissory note, the company received $12,500 on September 15, 2014, $87,500 on September 29, 2014 and is set to receive $50,000 on November 15, 2014. The proceeds of the loan are to be used for working capital purposes. To secure payment of the obligations due under the promissory note, the company granted a security interest to Mr. Francis of up to $200,000 from the net proceeds from the company's application for sale of its New Jersey corporate income tax losses for the years 2009 through 2013 via the 2014 State of New Jersey's Technology Business Tax Certificate Transfer Program offered by the New Jersey Economic Development Authority. The company has agreed to repay the principal along with any accrued and unpaid interest and the loan origination fee, from the sale proceeds of its State of New Jersey's Technology Business Tax Certificate Transfer Program which is expected to occur prior to the maturity date.

BioNeutral Group, Inc. announced delayed 10-Q filing

On 09/11/2014, BioNeutral Group, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

BioNeutral Group, Inc. announced delayed 10-Q filing

On 06/16/2014, BioNeutral Group, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BONU:US $0.00 USD -0.0001

BONU Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ecolab Inc $105.29 USD +0.86
Reckitt Benckiser Group PLC 5,225 GBp +155.00
STERIS Corp $65.43 USD +0.13
Clorox Co/The $103.82 USD +1.82
Procter & Gamble Co/The $92.00 USD +1.30
View Industry Companies
 

Industry Analysis

BONU

Industry Average

Valuation BONU Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.8x
Price/Book 0.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIONEUTRAL GROUP INC, please visit www.bioneutralgroup.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.